Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of antihypertensive treatment for white coat hypertension in the very elderly
2017-004004-22Phase 4Terminated
- Sponsor
- University of Sussex
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of indapamide and perindopril in white coat hypertension (WCH) (2 arms), sponsored by University of Sussex. Primary endpoint: Feasibility of treating white coat hypertension in the very elderly. Started Jan 2018; status: terminated.
02
Drugs
indapamideperindopril
03
Conditions
white coat hypertension (WCH)
Beyond the preview
Go deeper on 2017-004004-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004004-22.